Hennion & Walsh Asset Management, Inc. Insmed Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 43,934 shares of INSM stock, worth $3.2 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
43,934
Previous 87,456
49.76%
Holding current value
$3.2 Million
Previous $6.38 Million
52.49%
% of portfolio
0.14%
Previous 0.31%
Shares
16 transactions
Others Institutions Holding INSM
# of Institutions
473Shares Held
179MCall Options Held
2.27MPut Options Held
3.33M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.25 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$915 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$764 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$475 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.86B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...